VistaGen Therapeutics
VTGN
#9309
Rank
โ‚น5.79 B
Marketcap
โ‚น200.88
Share price
3.07%
Change (1 day)
-55.21%
Change (1 year)

Revenue for VistaGen Therapeutics (VTGN)

Revenue in 2024 (TTM): โ‚น58.84 Million

According to VistaGen Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น59.69 Million. a decrease over the revenue in the year 2023 that were of โ‚น86.71 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for VistaGen Therapeutics from 2008 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น59.9 M-30.92%
2023 โ‚น86.71 M-387.96%
2022 -โ‚น30.12 Million-126.76%
2021 โ‚น0.11 B137.6%
2020 โ‚น47.36 M
2019 N/A
2018 N/A
2013 N/A-100%
2012 โ‚น36.64 M-20.67%
2011 โ‚น46.19 M
2010 N/A
2009 N/A
2008 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA